Cary Street Partners Investment Advisory LLC Dexcom Inc Transaction History

Cary Street Partners Investment Advisory LLC

  • $2.63 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$86.06 - $137.93 $9,896 - $15,861
115 Added 11.08%
1,153 $107,000
Q2 2023

Aug 10, 2023
BUY
$112.47 - $130.98 $33,741 - $39,294
300 Added 40.65%
1,038 $133,000
Q1 2023

May 12, 2023
SELL
$104.0 - $122.92 $1,456 - $1,720
-14 Reduced 1.86%
738 $85,000
Q4 2022

Feb 14, 2023
BUY
$84.98 - $122.67 $63,904 - $92,247
752 New
752 $85,000
Q4 2020

Feb 12, 2021
SELL
$78.0 - $104.5 $7,800 - $10,450
-100 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$95.51 - $112.95 $9,551 - $11,295
100 New
100 $41,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email